Jazz Pharmaceuticals completed its $820 million acquisition of Actio Biosciences, gaining ABS-1230, a promising oral precision therapy for KCNT1-related epilepsy. ABS-1230 has shown potential in early trials to reduce seizures in children and holds multiple FDA designations, signaling accelerated development. This acquisition strengthens Jazz's rare disease pipeline and commitment to innovative epilepsy treatments. Jazz plans to rapidly advance ABS-1230 through clinical development and regulatory processes.
Jazz Pharmaceuticals' acquisition of Actio Biosciences provides context for readers. For those following the health sector, here is Pluang's market snapshot as of Sep 15, 2026 19:14 WIB: out of 91 priced US health stocks, 28 rose and 59 fell. Notable movers include Aurora Cannabis Inc (ACB) at USD 3.92 with a +2.89% change and Inovio Pharmaceuticals Inc (INO) at USD 1.21 with a +2.54% change.
Lake Street raised Flotek Industries' price target to $44, signaling a 65% upside from its current $26.68 price. This comes amid a securities fraud class action lawsuit over a canceled $400 million Puerto Rico contract, which caused the stock to plun...
Robinhood Markets is experiencing rapid growth in its prediction markets, with user engagement surging fifteen-fold to 4.7 billion event contracts traded in August. This growth is attracting positive analyst attention, with Cantor Fitzgerald maintain...
VICI Properties, a REIT specializing in gaming and entertainment properties, recently faced a 25% stock sell-off and a price target cut by Morgan Stanley from $31 to $29. Despite this, the new target still implies a 15.8% upside from the current pric...
Mid-America Apartment Communities, Inc. (MAA), a major apartment REIT focused on the U.S. Sunbelt region, faces mixed analyst opinions as it prepares for the BofA Securities 2026 Global Real Estate Conference on September 16. Analysts have recently a...
UBS lowered its price target for Comcast from $32 to $27, citing expected higher broadband subscriber losses, weaker theme-park results, and lower revenue and EBITDA in the near term. Comcast is also undergoing a major restructuring to spin off NBCUn...
